+7 (495) 796-94-33

Cart

Address: Moscow, Skolkovo

Bolshoy bulvar, 42 b1 Lab. 3A, 08. 559

view the map

Presentations

“Pharmacoeconomical cost and benefit analysis of radiopharmaceuticals for therapy of metastatic bone cancer”

Lev Voloznev, Karlova M., Chistyakov D.

NUCLEAR MEDICINE CONFERENCE “RADIOFARMA-2017”. Russia, Moscow. 29.06.2017

New opportunities of a radionuclide therapy in treating metastatic bone cancer

Krilov V.V., Kochetova T.U.

Russian National Scientific Conference «New technologies in clinical medicine» , 01/12/2015

Optimal visualization of Neuroendocrine tumors G3

Prof. Dr. Shiraev S.V.

XIX Russian Oncological Congress, 17/11/2015

Dose Escalation Study with 188Re-Zoledronic Acid in Patients with Painful Bone Metastases

Tatiana Kochetova, Valeriy Krylov, Lev Volosnev.

10th International Conference On Radiopharmaceutical Therapy (ICRT). Austria, Innsbruck, 04.05.2015

The effectivity of radiopharmaceuticals in treating breast cancer with bone metastasis

Dr. Krilov V.V.

RUSSCO «Breast Cancer». Moscow, 06/03/2015

Using111In-Octreotide in a Single-photon emission computed tomography research to diagnose neuroendocrine tumors

Prof. Dr. Shiraev S.V.

Russian Association of Radiologists Congress (PAP). Moscow, 06/11/2015

Re-188: New Era in radionuclide therapy

Dr. Krilov V.V.

Russian Association of Radiologists Congress (PAP). Moscow, 06/11/2015

Radionuclide therapy for metastatic bone cancer patients. New opportunities

Kochetova T.U.

Russian Association of Radiologists Congress (PAP). Moscow, 06/11/2015

Diagnostic and Treatment of Pancreatic Neuroendocrine tumors

Prof. Dr. Shiraev S.V.

XXII Congress of Hepato-Pancreato-Biliary Surgeons Association. Tashkent , Uzbekistan, 08/09/2015

Radionuclide theranostics in treating Neuroendocrine tumors

Prof. Dr. Shiraev S.V.

VIII Congress «Nevsky Radiological Forum». St. Petersburg, 11/04/2015

188Re-based radiopharmaceuticals for treatment bone metastasis. Comparative data.

Tatiana Kochetova.

World Rhenium Congress (1WCRe). Coimbatore, India, 11.09.2015

Radionuclide diagnostic and therapy for Neuroendocrine tumors

Prof. Dr. Shiraev S.V.

Neuroendocrine Tumors School. Moscow, 13/04/2015

Radionuclide therapy for bone metastasis

Dr. Krilov V.V.

Russian Oncological Therapy Conference (RUSSCO-MASCC). Moscow,14/05/2015

Theranostic approach for Neuroendocrine tumors: 111In, 68Ga, 177Lu

PhD Voloznev L.V.

Russian conference in Neuroendocrine tumors. Complex diagnostic and treatment issues. Moscow, 16/04/2015

Modern approach to manage Neuroendocrine tumors

PhD Rasylova N.V.

Russian conference in Neuroendocrine tumors. Complex diagnostic and treatment issues. Moscow, 16/04/2015

Radionuclide diagnostic and therapy for Neuroendocrine tumors in Russia and abroad. Complex cases discussion

Prof. Shiraev S.V.

Russian conference in Neuroendocrine tumors. Complex diagnostic and treatment issues. Moscow, 16/04/2015

Radionuclide therapy for bone metastasis. First International scientific conference

Dr. Krivol V.V.

Radiopharma – 2015. Moscow, 18/06/2015

Re-188 Zoledronic acid: from the first trial to latest clinical data

Kochetova T. U.

Clinical oncoradiology. Moscow, 19/03/2015

Radionuclide therapy for bone metastasis: latest opportunities and perspectives

Dr. Krilov V.V.

Science council A. Tsyb Medical Radiological Research Center, FSBI NMRRC of the Ministry of Health of the Russian Federation. Oblinsk, 29/04/2015